A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung

R. G. Crystal, A. Jaffe, S. Brody, A. Mastrangeli, N. G. McElvaney, M. Rosenfeld, C. S. Chu, C. Danel, J. Hay, T. Eissa

Research output: Contribution to journalReview articlepeer-review

12 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1 study, in cystic fibrosis patients, of the safety, toxicity, and biological efficacy of a single administration of a replication deficient, recombinant adenovirus carrying the cDNA of the normal cystic fibrosis transmembrane conductance regulator gene in the lung'. Together they form a unique fingerprint.